MARKET

VIVO

VIVO

Meridian Biosci
NASDAQ

Real-time Quotes | Nasdaq Last Sale

23.25
-0.32
-1.36%
After Hours: 23.44 +0.19 +0.82% 16:29 04/16 EDT
OPEN
23.54
PREV CLOSE
23.57
HIGH
23.54
LOW
21.64
VOLUME
1.03M
TURNOVER
--
52 WEEK HIGH
30.65
52 WEEK LOW
9.94
MARKET CAP
1.00B
P/E (TTM)
14.40
1D
5D
1M
3M
1Y
5Y
HIV/HBV/HCV Test Kits Market Analysis and In-depth study on Market Size Trends, Emerging Growth Factors and Regional Forecast to 2029 | FMI
Apr 16, 2021 (MARKITWIRED via COMTEX) -- A recent market study published by FMI "HIV/HBV/HCV Test Kits Market: Global Industry Analysis 2014-2018 and...
Markitwired · 1d ago
Anti-microbial/Anti-fungal Tests Market 2021 | Growth By Top Companies, Regions, Types, Applications and Forecasts by 2027 | Abbott Laboratories, bioMerieux SA, Bio-Rad Laboratories, Bruker Corporation
Apr 15, 2021 (MARKITWIRED via COMTEX) -- Microbial and fungal infections are a major cause of death globally and can even cause potential epidemics, creating...
Markitwired · 2d ago
Meridian Bioscience (VIVO) Dips More Than Broader Markets: What You Should Know
Meridian Bioscience (VIVO) closed the most recent trading day at $23.94, moving -1.4% from the previous trading session.
Zacks · 3d ago
Is Meridian Bioscience (NASDAQ:VIVO) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Simply Wall St. · 3d ago
Enteric Disease Testing Devices Market report 2021-2026 Covering Prime Factors and Competitive Outlook by Key Players
Apr 14, 2021 (WiredRelease via Comtex) -- "The new report published by Market.biz on the”Global Enteric Disease Testing Devices Market 2021“provides data...
marketresearch.biz · 3d ago
Blood Test Equipment Market 2021 Industry Share, Size, Growth, SWOT Analysis, Cost Structure, Top Companies, Worldwide Demand, Segments and Forecast Research 2026
Apr 14, 2021 (The Expresswire) -- The Blood Test Equipment Marketresearch report offers the breakdown of the industry by market size, rate of development,...
The Express Wire · 3d ago
Large Caliber Ammunition Market Size, sale 2021 drivers and applications are pertinent for sustenance during the forecast period 2026
The Express Wire · 3d ago
GenomeWeb Index Drops 3% for 2nd Consecutive Month
GuruFocus News · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of VIVO. Analyze the recent business situations of Meridian Biosci through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average VIVO stock price target is 32.67 with a high estimate of 34.00 and a low estimate of 32.00.
EPS
Institutional Holdings
Institutions: 293
Institutional Holdings: 45.88M
% Owned: 106.34%
Shares Outstanding: 43.15M
TypeInstitutionsShares
Increased
69
3.67M
New
28
657.62K
Decreased
60
2.48M
Sold Out
26
1.35M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.15%
Healthcare Equipment & Supplies
+0.17%
Key Executives
Non-Executive Chairman/Independent Director
David Phillips
Chief Executive Officer/Director
John Kenny
Chief Financial Officer/Executive Vice President/Chief Accounting Officer/Secretary
Bryan Baldasare
Executive Vice President
Tony Serafini-Lamanna
Executive Vice President
Lourdes Weltzien
Independent Director
James Anderson
Independent Director
Anthony Bihl
Independent Director
Dwight Ellingwood
Independent Director
John McIlwraith
Independent Director
John Rice
Independent Director
Catherine Sazdanoff
Independent Director
Felicia Williams
Declaration Date
Dividend Per Share
Ex-Div Date
01/22/2019
Dividend USD 0.125
02/01/2019
11/07/2018
Dividend USD 0.125
11/16/2018
07/24/2018
Dividend USD 0.125
08/09/2018
04/25/2018
Dividend USD 0.125
05/04/2018
01/24/2018
Dividend USD 0.125
02/02/2018
11/08/2017
Dividend USD 0.125
11/17/2017
07/25/2017
Dividend USD 0.125
08/03/2017
04/25/2017
Dividend USD 0.125
05/04/2017
01/25/2017
Dividend USD 0.125
02/02/2017
11/09/2016
Dividend USD 0.2
11/17/2016
07/26/2016
Dividend USD 0.2
08/04/2016
04/26/2016
Dividend USD 0.2
05/05/2016
01/26/2016
Dividend USD 0.2
02/04/2016
11/04/2015
Dividend USD 0.2
11/12/2015
07/21/2015
Dividend USD 0.2
07/30/2015
04/21/2015
Dividend USD 0.2
04/30/2015
01/21/2015
Dividend USD 0.2
01/29/2015
11/05/2014
Dividend USD 0.2
11/13/2014
07/22/2014
Dividend USD 0.2
07/31/2014
04/22/2014
Dividend USD 0.2
05/01/2014
01/21/2014
Dividend USD 0.2
01/30/2014
11/06/2013
Dividend USD 0.19
11/14/2013
07/24/2013
Dividend USD 0.19
08/01/2013
04/24/2013
Dividend USD 0.19
05/01/2013
12/04/2012
Dividend USD 0.19
12/12/2012
11/07/2012
Dividend USD 0.19
11/15/2012
07/25/2012
Dividend USD 0.19
08/02/2012
04/25/2012
Dividend USD 0.19
05/02/2012
01/24/2012
Dividend USD 0.19
02/01/2012
11/09/2011
Dividend USD 0.19
11/17/2011
07/20/2011
Dividend USD 0.19
07/28/2011
04/20/2011
Dividend USD 0.19
04/28/2011
01/19/2011
Dividend USD 0.19
01/27/2011
11/10/2010
Dividend USD 0.19
11/18/2010
07/19/2010
Dividend USD 0.19
07/27/2010
04/19/2010
Dividend USD 0.19
04/27/2010
01/20/2010
Dividend USD 0.19
01/28/2010
11/11/2009
Dividend USD 0.17
11/19/2009
07/15/2009
Dividend USD 0.17
07/23/2009
04/15/2009
Dividend USD 0.17
04/22/2009
01/21/2009
Dividend USD 0.17
01/29/2009
11/11/2008
Dividend USD 0.14
11/19/2008
07/16/2008
Dividend USD 0.14
07/28/2008
04/16/2008
Dividend USD 0.14
04/24/2008
01/21/2008
Dividend USD 0.14
01/29/2008
11/13/2007
Dividend USD 0.11
11/21/2007
07/18/2007
Dividend USD 0.11
07/26/2007
04/18/2007
Dividend USD 0.16
04/26/2007
01/18/2007
Dividend USD 0.16
01/25/2007
11/15/2006
Dividend USD 0.115
11/22/2006
More
About VIVO
Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers. Its segments include Diagnostics and Life Science. The Diagnostics segment includes manufacturing operations in Cincinnati, and the sale and distribution of diagnostic test kits in the countries consisting of North, Central and South America; Europe, the Middle East and Africa (EMEA), and other countries outside of the Americas and EMEA. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany, and Sydney, Australia.

Webull offers kinds of Meridian Bioscience, Inc. stock information, including NASDAQ:VIVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIVO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VIVO stock methods without spending real money on the virtual paper trading platform.